Registration Options

Register for the meeting.

Session Time and Location

Date: Wednesday, 04/21/2021

Time: 12:00 PM (view in the schedule)

Session Summary

Migraine is common in children and adolescents with a prevalence of 8-23% by age 15 years and is associated with significant impact on academic performance, social functioning, peer/family relationships – particularly with recurrent, severe presentations. Association with anxiety and depressive disorders is common, warranting critical evaluation among both psychiatric and neurologic pharmacists. A variety of treatment strategies have been evaluated, including acute/preventive, behavioral/lifestyle, and complementary/alternative strategies. Recent updates in treatment guidelines, advancement in literature, and caregiver interest in complementary/alternative approaches make this a timely topic for psychiatric and neurologic pharmacists. The Child and Adolescent Psychiatry Community idea exchange will allow for high-level discussion of migraine treatment updates, clinical pearls, and perspectives from a neurologic pharmacist – allowing for much needed attention to this important topic. This will be a special opportunity to share tools, ideas, and current practices among this unique patient population.

Faculty Information and Disclosures

Andrea Calvert, PharmD
Danielle Stutzman, PharmD, BCPP
Sandra Mullen, PharmD, BCPP

View biographical information and disclosures